Matches in Nanopublications for { ?s ?p "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP292480.RAfdplGT0w0kx9o3int6aaYWt9vLCVrgYIoZAb20jZnQo130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292480.RAfdplGT0w0kx9o3int6aaYWt9vLCVrgYIoZAb20jZnQo130_provenance.
- NP397058.RAZRY1kyslkLPUhwWbhxAQ_XkYW-gUm2YQlfipL7TyO0I130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397058.RAZRY1kyslkLPUhwWbhxAQ_XkYW-gUm2YQlfipL7TyO0I130_provenance.
- NP397366.RAcuB7ZGHhb9A0l0Dbgq9SWiq5lPSRW2Tf4wONYf3TkEk130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397366.RAcuB7ZGHhb9A0l0Dbgq9SWiq5lPSRW2Tf4wONYf3TkEk130_provenance.
- assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1124392.RA0hBay3TfykFDirlfu6jpeX0wxzt1u5hsDbQRzqILiLU130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124392.RA0hBay3TfykFDirlfu6jpeX0wxzt1u5hsDbQRzqILiLU130_provenance.
- NP1124398.RAybPT2SZVKqwzneRluzmW7OgPjN5aixdIXA97FU5YUvE130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124398.RAybPT2SZVKqwzneRluzmW7OgPjN5aixdIXA97FU5YUvE130_provenance.
- NP1124399.RAbE-UdjYF8tw2URn96hJVT3qLY2g-r9XjLNKxtiWcIic130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124399.RAbE-UdjYF8tw2URn96hJVT3qLY2g-r9XjLNKxtiWcIic130_provenance.
- NP1124393.RAPQJw2GgVCJToxMTWk2qCDwC7mcRfh0EoohfY1TUKENg130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124393.RAPQJw2GgVCJToxMTWk2qCDwC7mcRfh0EoohfY1TUKENg130_provenance.
- NP1124397.RAPsAZKw78l0wKu6ctoA6gWJT4GRhunr9uWQ5SgJxts98130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124397.RAPsAZKw78l0wKu6ctoA6gWJT4GRhunr9uWQ5SgJxts98130_provenance.
- NP586084.RAulfgW6N3eUYlxh_hC85bsbzdukX9NX5cE-bw5k_5mR8130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586084.RAulfgW6N3eUYlxh_hC85bsbzdukX9NX5cE-bw5k_5mR8130_provenance.
- NP290025.RApHyAqiPYjAx8WsTmKW9ODdHicnfwrCEdQR8jI3Tqamg130_assertion description "[We identified Lin(-)HLADR(-)CD33(+)CD16(+) cells and CD14(++)CD16(-) monocytes as the main TLR5 producers, especially in samples of conventionally treated patients developing GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290025.RApHyAqiPYjAx8WsTmKW9ODdHicnfwrCEdQR8jI3Tqamg130_provenance.